Why Endo International (ENDP) Stock Is Plunging On Friday?
- Oops!Something went wrong.Please try again later.
Shares of Endo International (NASDAQ: ENDP) came in crashing after The Wall Street Journal reported that the drugmaker had engaged Alvarez & Marsal to look into a potential financial restructuring.
The report of a potential restructuring is only the latest of woes Endo has faced related to a flood of opioid-related lawsuits.
Endo hasn't confirmed that it hired a financial restructuring advisor. However, the Journal stated that Endo brought in Alvarez & Marsal to explore options for reducing its litigation-related liabilities and debt load of more than $8 billion.
The company and Alvarez didn't immediately respond to requests for comment.
As of July, nearly 3,000 legal cases were pending against Endo from states, counties, cities, Native American tribes, and over 300 lawsuits from healthcare institutions.
Related: Opioid Settlement Of B Between Drug Companies, States.
Price Action: ENDP shares are down 35.7% at $2.29 during the market session on the last check Friday.
See more from Benzinga
House Committee Questions Eli Lilly, Sanofi, Novo Nordisk On 'Unacceptably High' Insulin Prices
Progenity Stock Drops To 52-Week Low On M Equity Capital Raise
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.